MTOR and subependymal giant cell astrocytoma: Widely used in the treatment of subependymal giant cell astrocytoma (SEGA) in patients with TSC, including children <2 years of age, mTOR inhibitors have been shown to be beneficial for tumor control and also seizure control in this patient population (24–26).